As of 2025-11-08, the EV/EBITDA ratio of Pliant Therapeutics Inc (PLRX) is -0.19. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PLRX's latest enterprise value is 41.76 mil USD. PLRX's TTM EBITDA according to its financial statements is -219.95 mil USD. Dividing these 2 quantities gives us the above PLRX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2025-11-07 | -0.19 |
| 2025-11-06 | -0.17 |
| 2025-11-05 | -0.20 |
| 2025-11-04 | -0.19 |
| 2025-11-03 | -0.21 |
| 2025-10-31 | -0.21 |
| 2025-10-30 | -0.20 |
| 2025-10-29 | -0.23 |
| 2025-10-28 | -0.24 |
| 2025-10-27 | -0.25 |
| 2025-10-24 | -0.25 |
| 2025-10-23 | -0.23 |
| 2025-10-22 | -0.25 |
| 2025-10-21 | -0.27 |
| 2025-10-20 | -0.20 |
| 2025-10-17 | -0.18 |
| 2025-10-16 | -0.20 |
| 2025-10-15 | -0.18 |
| 2025-10-14 | -0.16 |
| 2025-10-13 | -0.16 |
| 2025-10-10 | -0.15 |
| 2025-10-09 | -0.17 |
| 2025-10-08 | -0.17 |
| 2025-10-07 | -0.16 |
| 2025-10-06 | -0.16 |
| 2025-10-03 | -0.17 |
| 2025-10-02 | -0.16 |
| 2025-10-01 | -0.15 |
| 2025-09-30 | -0.16 |
| 2025-09-29 | -0.16 |
| 2025-09-26 | -0.17 |
| 2025-09-25 | -0.15 |
| 2025-09-24 | -0.15 |
| 2025-09-23 | -0.15 |
| 2025-09-22 | -0.16 |
| 2025-09-19 | -0.14 |
| 2025-09-18 | -0.16 |
| 2025-09-17 | -0.15 |
| 2025-09-16 | -0.17 |
| 2025-09-15 | -0.17 |
| 2025-09-12 | -0.19 |
| 2025-09-11 | -0.20 |
| 2025-09-10 | -0.21 |
| 2025-09-09 | -0.23 |
| 2025-09-08 | -0.23 |
| 2025-09-05 | -0.26 |
| 2025-09-04 | -0.20 |
| 2025-09-03 | -0.22 |
| 2025-09-02 | -0.21 |
| 2025-08-29 | -0.20 |